|

LUTATHERA® (Lutetium Lu 177 dotatate) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Lutathera

Pipeline

Phase 1/2: 1

Top Sponsors

  • Nationwide Children's Hospital1

Indications

  • Refractory Primary Central Nervous System Neoplasm1
  • Refractory Malignant Glioma1
  • Refractory Diffuse Intrinsic Pontine Glioma1
  • Recurrent Primary Central Nervous System Neoplasm1
  • Anaplastic Ependymoma1

Aurora, Colorado1 trial

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Children's Hospital Colorado

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.